title: Reply to: economic evaluation of second generation pneumococcal conjugate vaccines in Norway.
authors.forename: Raymond
authors.initials: R
authors.lastname: Farkouh
authors.forename: Rogier
authors.initials: R
authors.lastname: Klok
authors.forename: Craig
authors.initials: C
authors.lastname: Roberts
authors.forename: Asbjørn
authors.initials: A
authors.lastname: Mack
authors.forename: David
authors.initials: D
authors.lastname: Strutton
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008586:Meningitis, Pneumococcal / Q000517:prevention & control*; D010033:Otitis Media / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000191:economics*; D011018:Pneumonia, Pneumococcal / Q000517:prevention & control*
chemical_list: D022242:Pneumococcal Vaccines